Topical administration of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol
US6121329A · kind A · utility
27Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 1997 |
| Grant date | Sep 19, 2000 |
| Priority date | — |
| Expiry date | Aug 27, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An external preparation for topical administration which aims at inhibiting rejection reactions at organ or bone marrow transplantation or treating autoimmune diseases or allergic diseases and contains as the active ingredient 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol or a pharmaceutically acceptable acid addition salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.